Predictive Oncology
POAI
POAI
32 hedge funds and large institutions have $1.41M invested in Predictive Oncology in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
13% less capital invested
Capital invested by funds: $1.62M → $1.41M (-$205K)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$25K | |
| 2 | +$19.7K | |
| 3 | +$12.6K | |
| 4 |
SWA
Sax Wealth Advisors
Parsippany,
New Jersey
|
+$12.2K |
| 5 |
Jane Street
New York
|
+$6.5K |
Top Sellers
| 1 | -$28.2K | |
| 2 | -$4.41K | |
| 3 | -$3K | |
| 4 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
-$2.91K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.67K |